65 results on '"Leow AD"'
Search Results
2. Baseline connectome modular abnormalities in the childhood phase of a longitudinal study on individuals with chromosome 22q11.2 deletion syndrome
- Author
-
Zhan, L, Jenkins, LM, Zhang, A, Conte, G, Forbes, A, Harvey, D, Angkustsiri, K, Goodrich-Hunsaker, NJ, Durdle, C, Lee, A, Schumann, C, Carmichael, O, Kalish, K, Leow, AD, and Simon, TJ
- Subjects
Male ,intrinsic geometry ,Pediatric Research Initiative ,Adolescent ,brain connectome ,Article ,Functional Laterality ,diffusion MRI ,Clinical Research ,Neural Pathways ,DiGeorge Syndrome ,Connectome ,Humans ,Cluster Analysis ,2.1 Biological and endogenous factors ,Longitudinal Studies ,Aetiology ,Child ,22q11DS ,modularity ,Pediatric ,Neurosciences ,Brain ,Experimental Psychology ,Brain Disorders ,Mental Health ,Female ,Cognitive Sciences - Abstract
© 2017 Wiley Periodicals, Inc. Occurring in at least 1 in 3,000 live births, chromosome 22q11.2 deletion syndrome (22q11DS) produces a complex phenotype that includes a constellation of medical complications such as congenital cardiac defects, immune deficiency, velopharyngeal dysfunction, and characteristic facial dysmorphic features. There is also an increased incidence of psychiatric diagnosis, especially intellectual disability and ADHD in childhood, lifelong anxiety, and a strikingly high rate of schizophrenia spectrum disorders, which occur in around 30% of adults with 22q11DS. Using innovative computational connectomics, we studied how 22q11DS affects high-level network signatures of hierarchical modularity and its intrinsic geometry in 55 children with confirmed 22q11DS and 27 Typically Developing (TD) children. Results identified 3 subgroups within our 22q11DS sample using a K-means clustering approach based on several midline structural measures-of-interests. Each subgroup exhibited distinct patterns of connectome abnormalities. Subtype 1, containing individuals with generally healthy-looking brains, exhibited no significant differences in either modularity or intrinsic geometry when compared with TD. By contrast, the more anomalous 22q11DS Subtypes 2 and 3 brains revealed significant modular differences in the right hemisphere, while Subtype 3 (the most anomalous anatomy) further exhibited significantly abnormal connectome intrinsic geometry in the form of left–right temporal disintegration. Taken together, our findings supported an overall picture of (a) anterior-posteriorly differential interlobar frontotemporal/frontoparietal dysconnectivity in Subtypes 2 and 3 and (b) differential intralobar dysconnectivity in Subtype 3. Our ongoing studies are focusing on whether these subtypes and their connnectome signatures might be valid biomarkers for predicting the degree of psychosis-proneness risk found in 22q11DS. Hum Brain Mapp 39:232–248, 2018. © 2017 Wiley Periodicals, Inc.
- Published
- 2018
3. Brain Structure and Obesity
- Author
-
Ho, AJ, primary, Raji, CA, additional, Parikshak, NN, additional, Becker, JT, additional, Lopez, OL, additional, Kuller, LH, additional, Hua, X, additional, Leow, AD, additional, Toga, AW, additional, and Thompson, PM, additional
- Published
- 2009
- Full Text
- View/download PDF
4. Using a Novel Digital Go/No-Go to Dissociate Intra-subject Temporal Fluctuations in Reaction Time and Accuracy.
- Author
-
Nguyen TM, Ross MK, Ning E, Kabir S, Cladek AT, Barve A, Kennelly E, Hussain F, Duffecy J, Langenecker SL, Zulueta J, Demos AP, Ajilore OA, and Leow AD
- Abstract
Impulsivity can be a risk factor for serious complications for those with mood disorders. To understand intra-individual impulsivity variability, we analyzed longitudinal data of a novel gamified digital Go/No-Go (GNG) task in a clinical sample (n=43 mood disorder participants, n=17 healthy controls) and an open-science sample (n=121, self-reported diagnoses). With repeated measurements within-subject, we disentangled two aspects of GNG: reaction time and accuracy in response inhibition (i.e., incorrect No-Go trials) with respect to diurnal and potential learning effects. Mixed-effects models showed diurnal effects in reaction time but not accuracy, with a significant effect of hour on reaction time in the clinical sample and the open-science sample. Moreover, subjects improved on their response inhibition but not reaction time. Additionally, significant interactions emerged between depression symptom severity and time-of-day in both samples, supporting that repeated administration of our GNG task can yield mood-dependent circadian rhythm-aware biomarkers of neurocognitive function.
- Published
- 2024
- Full Text
- View/download PDF
5. Temporal Alterations in White Matter in An App Knock-In Mouse Model of Alzheimer's Disease.
- Author
-
Morrissey ZD, Gao J, Shetti A, Li W, Zhan L, Li W, Fortel I, Saido T, Saito T, Ajilore O, Cologna SM, Lazarov O, and Leow AD
- Subjects
- Animals, Humans, Mice, Amyloid beta-Protein Precursor genetics, Amyloid beta-Protein Precursor metabolism, Brain metabolism, Diffusion Tensor Imaging methods, Disease Models, Animal, Alzheimer Disease diagnostic imaging, Alzheimer Disease genetics, Alzheimer Disease metabolism, White Matter metabolism
- Abstract
Alzheimer's disease (AD) is the most common form of dementia and results in neurodegeneration and cognitive impairment. White matter (WM) is affected in AD and has implications for neural circuitry and cognitive function. The trajectory of these changes across age, however, is still not well understood, especially at earlier stages in life. To address this, we used the App
NL-G-F/NL-G-F knock-in (APPKI) mouse model that harbors a single copy knock-in of the human amyloid precursor protein ( APP ) gene with three familial AD mutations. We performed in vivo diffusion tensor imaging (DTI) to study how the structural properties of the brain change across age in the context of AD. In late age APPKI mice, we observed reduced fractional anisotropy (FA), a proxy of WM integrity, in multiple brain regions, including the hippocampus, anterior commissure (AC), neocortex, and hypothalamus. At the cellular level, we observed greater numbers of oligodendrocytes in middle age (prior to observations in DTI) in both the AC, a major interhemispheric WM tract, and the hippocampus, which is involved in memory and heavily affected in AD, prior to observations in DTI. Proteomics analysis of the hippocampus also revealed altered expression of oligodendrocyte-related proteins with age and in APPKI mice. Together, these results help to improve our understanding of the development of AD pathology with age, and imply that middle age may be an important temporal window for potential therapeutic intervention., Competing Interests: The authors declare no competing financial interests., (Copyright © 2024 Morrissey et al.)- Published
- 2024
- Full Text
- View/download PDF
6. A Review on Smartphone Keystroke Dynamics as a Digital Biomarker for Understanding Neurocognitive Functioning.
- Author
-
Nguyen TM, Leow AD, and Ajilore O
- Abstract
Can digital technologies provide a passive unobtrusive means to observe and study cognition outside of the laboratory? Previously, cognitive assessments and monitoring were conducted in a laboratory or clinical setting, allowing for a cross-sectional glimpse of cognitive states. In the last decade, researchers have been utilizing technological advances and devices to explore ways of assessing cognition in the real world. We propose that the virtual keyboard of smartphones, an increasingly ubiquitous digital device, can provide the ideal conduit for passive data collection to study cognition. Passive data collection occurs without the active engagement of a participant and allows for near-continuous, objective data collection. Most importantly, this data collection can occur in the real world, capturing authentic datapoints. This method of data collection and its analyses provide a more comprehensive and potentially more suitable insight into cognitive states, as intra-individual cognitive fluctuations over time have shown to be an early manifestation of cognitive decline. We review different ways passive data, centered around keystroke dynamics, collected from smartphones, have been used to assess and evaluate cognition. We also discuss gaps in the literature where future directions of utilizing passive data can continue to provide inferences into cognition and elaborate on the importance of digital data privacy and consent.
- Published
- 2023
- Full Text
- View/download PDF
7. A Novel Approach to Clustering Accelerometer Data for Application in Passive Predictions of Changes in Depression Severity.
- Author
-
Ross MK, Tulabandhula T, Bennett CC, Baek E, Kim D, Hussain F, Demos AP, Ning E, Langenecker SA, Ajilore O, and Leow AD
- Subjects
- Humans, Affect, Machine Learning, Accelerometry, Depression diagnosis, Smartphone
- Abstract
The treatment of mood disorders, which can become a lifelong process, varies widely in efficacy between individuals. Most options to monitor mood rely on subjective self-reports and clinical visits, which can be burdensome and may not portray an accurate representation of what the individual is experiencing. A passive method to monitor mood could be a useful tool for those with these disorders. Some previously proposed models utilized sensors from smartphones and wearables, such as the accelerometer. This study examined a novel approach of processing accelerometer data collected from smartphones only while participants of the open-science branch of the BiAffect study were typing. The data were modeled by von Mises-Fisher distributions and weighted networks to identify clusters relating to different typing positions unique for each participant. Longitudinal features were derived from the clustered data and used in machine learning models to predict clinically relevant changes in depression from clinical and typing measures. Model accuracy was approximately 95%, with 97% area under the ROC curve (AUC). The accelerometer features outperformed the vast majority of clinical and typing features, which suggested that this new approach to analyzing accelerometer data could contribute towards unobtrusive detection of changes in depression severity without the need for clinical input.
- Published
- 2023
- Full Text
- View/download PDF
8. Hippocampal functional connectivity across age in an App knock-in mouse model of Alzheimer's disease.
- Author
-
Morrissey ZD, Gao J, Zhan L, Li W, Fortel I, Saido T, Saito T, Bakker A, Mackin S, Ajilore O, Lazarov O, and Leow AD
- Abstract
Introduction: Alzheimer's disease (AD) is a progressive neurodegenerative disease. The early processes of AD, however, are not fully understood and likely begin years before symptoms manifest. Importantly, disruption of the default mode network, including the hippocampus, has been implicated in AD., Methods: To examine the role of functional network connectivity changes in the early stages of AD, we performed resting-state functional magnetic resonance imaging (rs-fMRI) using a mouse model harboring three familial AD mutations ( App
NL-G-F/NL-G-F knock-in, APPKI) in female mice in early, middle, and late age groups. The interhemispheric and intrahemispheric functional connectivity (FC) of the hippocampus was modeled across age., Results: We observed higher interhemispheric functional connectivity (FC) in the hippocampus across age. This was reduced, however, in APPKI mice in later age. Further, we observed loss of hemispheric asymmetry in FC in APPKI mice., Discussion: Together, this suggests that there are early changes in hippocampal FC prior to heavy onset of amyloid β plaques, and which may be clinically relevant as an early biomarker of AD., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Morrissey, Gao, Zhan, Li, Fortel, Saido, Saito, Bakker, Mackin, Ajilore, Lazarov and Leow.)- Published
- 2023
- Full Text
- View/download PDF
9. Signed graph representation learning for functional-to-structural brain network mapping.
- Author
-
Tang H, Guo L, Fu X, Wang Y, Mackin S, Ajilore O, Leow AD, Thompson PM, Huang H, and Zhan L
- Subjects
- Humans, Brain Mapping, Learning, Brain diagnostic imaging, Neuroimaging, Neurodegenerative Diseases
- Abstract
MRI-derived brain networks have been widely used to understand functional and structural interactions among brain regions, and factors that affect them, such as brain development and diseases. Graph mining on brain networks can facilitate the discovery of novel biomarkers for clinical phenotypes and neurodegenerative diseases. Since brain functional and structural networks describe the brain topology from different perspectives, exploring a representation that combines these cross-modality brain networks has significant clinical implications. Most current studies aim to extract a fused representation by projecting the structural network to the functional counterpart. Since the functional network is dynamic and the structural network is static, mapping a static object to a dynamic object may not be optimal. However, mapping in the opposite direction (i.e., from functional to structural networks) are suffered from the challenges introduced by negative links within signed graphs. Here, we propose a novel graph learning framework, named as Deep Signed Brain Graph Mining or DSBGM, with a signed graph encoder that, from an opposite perspective, learns the cross-modality representations by projecting the functional network to the structural counterpart. We validate our framework on clinical phenotype and neurodegenerative disease prediction tasks using two independent, publicly available datasets (HCP and OASIS). Our experimental results clearly demonstrate the advantages of our model compared to several state-of-the-art methods., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
10. Smartphone accelerometer data as a proxy for clinical data in modeling of bipolar disorder symptom trajectory.
- Author
-
Bennett CC, Ross MK, Baek E, Kim D, and Leow AD
- Abstract
Being able to track and predict fluctuations in symptoms of mental health disorders such as bipolar disorder outside the clinic walls is critical for expanding access to care for the global population. To that end, we analyze a dataset of 291 individuals from a smartphone app targeted at bipolar disorder, which contains rich details about their smartphone interactions (including typing dynamics and accelerometer motion) collected everyday over several months, along with more traditional clinical features. The aim is to evaluate whether smartphone accelerometer data could serve as a proxy for traditional clinical data, either by itself or in combination with typing dynamics. Results show that accelerometer data improves the predictive performance of machine learning models by nearly 5% over those previously reported in the literature based only on clinical data and typing dynamics. This suggests it is possible to elicit essentially the same "information" about bipolar symptomology using different data sources, in a variety of settings., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
11. A Hierarchical Graph Learning Model for Brain Network Regression Analysis.
- Author
-
Tang H, Guo L, Fu X, Qu B, Ajilore O, Wang Y, Thompson PM, Huang H, Leow AD, and Zhan L
- Abstract
Brain networks have attracted increasing attention due to the potential to better characterize brain dynamics and abnormalities in neurological and psychiatric conditions. Recent years have witnessed enormous successes in deep learning. Many AI algorithms, especially graph learning methods, have been proposed to analyze brain networks. An important issue for existing graph learning methods is that those models are not typically easy to interpret. In this study, we proposed an interpretable graph learning model for brain network regression analysis. We applied this new framework on the subjects from Human Connectome Project (HCP) for predicting multiple Adult Self-Report (ASR) scores. We also use one of the ASR scores as the example to demonstrate how to identify sex differences in the regression process using our model. In comparison with other state-of-the-art methods, our results clearly demonstrate the superiority of our new model in effectiveness, fairness, and transparency., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Tang, Guo, Fu, Qu, Ajilore, Wang, Thompson, Huang, Leow and Zhan.)
- Published
- 2022
- Full Text
- View/download PDF
12. rest2vec: Vectorizing the resting-state functional connectome using graph embedding.
- Author
-
Morrissey ZD, Zhan L, Ajilore O, and Leow AD
- Subjects
- Humans, Magnetic Resonance Imaging methods, Rest, Brain physiology, Connectome methods, Image Processing, Computer-Assisted methods, Machine Learning
- Abstract
Resting-state functional magnetic resonance imaging (rs-fMRI) is widely used in connectomics for studying the functional relationships between regions of the human brain. rs-fMRI connectomics, however, has inherent analytical challenges, such as how to properly model negative correlations between BOLD time series. In addition, functional relationships between brain regions do not necessarily correspond to their anatomical distance, making the functional topology of the brain less well understood. Recent machine learning techniques, such as word2vec, have used embedding methods to map high-dimensional data into vector spaces, where words with more similar meanings are mapped closer to one another. Inspired by this approach, we have developed the graph embedding pipeline rest2vec for studying the vector space of functional connectomes. We demonstrate how rest2vec uses the phase angle spatial embedding (PhASE) method with dimensionality reduction to embed the connectome into lower dimensions, where the functional definition of a brain region is represented continuously in an intrinsic "functional space." Furthermore, we show how the "functional distance" between brain regions in this space can be applied to discover biologically-relevant connectivity gradients. Interestingly, rest2vec can be conceptualized in the context of the recently proposed maximum mean discrepancy (MMD) metric, followed by a double-centering approach seen in kernel PCA. In sum, rest2vec creates a low-dimensional representation of the rs-fMRI connectome where brain regions are mapped according to their functional relationships, giving a more informed understanding of the functional organization of the brain., Competing Interests: Declaration of Competing Interest The authors declare no conflicts of interest., (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
13. Real-Time Monitoring: A Key Element in Personalized Health and Precision Health.
- Author
-
Zulueta J, Leow AD, and Ajilore O
- Abstract
Current management of psychiatric disorders relies heavily on retrospective, subjective reports provided by patients and their families. Consequently, psychiatric services are often provisioned inefficiently and with suboptimal outcomes. Recent advances in computing and sensor technologies have enabled the development of real-time monitoring systems for the diagnosis and management of psychiatric disorders. The state of these technologies is rapidly evolving, with passive monitoring and predictive modeling as two areas that have great potential to affect psychiatric care. Although outpatient psychiatry probably stands to benefit the most from the use of real-time monitoring technologies, there are also several ways in which inpatient psychiatry may also benefit. As the capabilities of these technologies increase and their use becomes more common, many ethical and legal issues will need to be considered. The role of governmental regulatory bodies and nongovernmental organizations in providing oversight of the implementation of these technologies is an active area of discussion., Competing Interests: Dr. Leow reports serving on the advisory board for Buoy Health and being a cofounder of KeyWise. Dr. Ajilore reports serving on the advisory board of Embodied Labs and Blueprint Health, being a cofounder of KeyWise, and being a consultant for Quartet Health. Dr. Zulueta reports no financial relationship with commercial interests., (Copyright © by the American Psychiatric Association.)
- Published
- 2020
- Full Text
- View/download PDF
14. A GENERALIZED FRAMEWORK OF PATHLENGTH ASSOCIATED COMMUNITY ESTIMATION FOR BRAIN STRUCTURAL NETWORK.
- Author
-
Chen Y, Tang H, Guo L, Peven JC, Huang H, Leow AD, Lamar M, and Zhan L
- Abstract
Diffusion MRI-derived brain structural network has been widely used in brain research and community or modular structure is one of popular network features, which can be extracted from network edge-derived pathlengths. Conceptually, brain structural network edges represent the connecting strength between pair of nodes, thus non-negative. The pathlength. Many studies have demonstrated that each brain network edge can be affected by many confounding factors (e.g. age, sex, etc.) and this influence varies on each edge. However, after applying generalized linear regression to remove those confounding's effects, some network edges may become negative, which leads to barriers in extracting the community structure. In this study, we propose a novel generalized framework to solve this negative edge issue in extracting the modular structure from brain structural network. We have compared our framework with traditional Q method. The results clearly demonstrated that our framework has significant advantages in both stability and sensitivity.
- Published
- 2020
- Full Text
- View/download PDF
15. Differentiating weight-restored anorexia nervosa and body dysmorphic disorder using neuroimaging and psychometric markers.
- Author
-
Vaughn DA, Kerr WT, Moody TD, Cheng GK, Morfini F, Zhang A, Leow AD, Strober MA, Cohen MS, and Feusner JD
- Subjects
- Adolescent, Adult, Biomarkers, Data Analysis, Diagnosis, Differential, Female, Humans, Image Processing, Computer-Assisted methods, Magnetic Resonance Imaging, Male, ROC Curve, Young Adult, Anorexia Nervosa diagnosis, Anorexia Nervosa etiology, Body Dysmorphic Disorders diagnosis, Body Dysmorphic Disorders etiology, Neuroimaging methods, Psychometrics methods
- Abstract
Anorexia nervosa (AN) and body dysmorphic disorder (BDD) are potentially life-threatening conditions whose partially overlapping phenomenology-distorted perception of appearance, obsessions/compulsions, and limited insight-can make diagnostic distinction difficult in some cases. Accurate diagnosis is crucial, as the effective treatments for AN and BDD differ. To improve diagnostic accuracy and clarify the contributions of each of the multiple underlying factors, we developed a two-stage machine learning model that uses multimodal, neurobiology-based, and symptom-based quantitative data as features: task-based functional magnetic resonance imaging data using body visual stimuli, graph theory metrics of white matter connectivity from diffusor tensor imaging, and anxiety, depression, and insight psychometric scores. In a sample of unmedicated adults with BDD (n = 29), unmedicated adults with weight-restored AN (n = 24), and healthy controls (n = 31), the resulting model labeled individuals with an accuracy of 76%, significantly better than the chance accuracy of 35% ([Formula: see text]). In the multivariate model, reduced white matter global efficiency and better insight were associated more with AN than with BDD. These results improve our understanding of the relative contributions of the neurobiological characteristics and symptoms of these disorders. Moreover, this approach has the potential to aid clinicians in diagnosis, thereby leading to more tailored therapy., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2019
- Full Text
- View/download PDF
16. From Return of Information to Return of Value: Ethical Considerations when Sharing Individual-Level Research Data.
- Author
-
Nebeker C, Leow AD, and Moore RC
- Subjects
- Confidentiality, Humans, Alzheimer Disease, Biomedical Research ethics, Information Dissemination ethics, Medical Informatics ethics, Medical Informatics trends
- Abstract
The implementation of digital health technologies into research studies for Alzheimer's disease and other clinical populations is on the rise. Digital tools and strategies create opportunities to further expand the framework for conducting research beyond the traditional medical research model. The combination of participatory and community-based research methods, electronic health records, and the creation of multi-dimensional, large-scale research platforms to support precision medicine, along with the Internet of Things era, have led to more engaged and informed research participants. Research participants increasingly possess an expectation they will play a critical role as partners in the design and conduct of research. Moreover, there is growing interest among research participants to have access to individual-level research data in real-time and/or at study completion. The traditional medical research model is largely one-directional where participants contribute data that is analyzed by researchers to yield generalizable knowledge. In this Ethics Review, we discuss a framework for a more nuanced intermediate research model, which is largely bidirectional and individually customized. Based on the seven ethical guidelines adopted by the National Institutes of Health, we speak to the ethical challenges of this intermediate type research. We also introduce a concept we are calling "MyTerms," in which prospective participants tailor the terms and conditions of informed consent to their personalized preferences for receiving information, including research results. Digital health technologies offer a convenient and flexible approach for researchers to develop protocols that make it possible for participants to obtain access to their study data in a personalized and meaningful way.
- Published
- 2019
- Full Text
- View/download PDF
17. NeuroCave: A web-based immersive visualization platform for exploring connectome datasets.
- Author
-
Keiriz JJG, Zhan L, Ajilore O, Leow AD, and Forbes AG
- Abstract
We introduce NeuroCave, a novel immersive visualization system that facilitates the visual inspection of structural and functional connectome datasets. The representation of the human connectome as a graph enables neuroscientists to apply network-theoretic approaches in order to explore its complex characteristics. With NeuroCave, brain researchers can interact with the connectome-either in a standard desktop environment or while wearing portable virtual reality headsets (such as Oculus Rift, Samsung Gear, or Google Daydream VR platforms)-in any coordinate system or topological space, as well as cluster brain regions into different modules on-demand. Furthermore, a default side-by-side layout enables simultaneous, synchronized manipulation in 3D, utilizing modern GPU hardware architecture, and facilitates comparison tasks across different subjects or diagnostic groups or longitudinally within the same subject. Visual clutter is mitigated using a state-of-the-art edge bundling technique and through an interactive layout strategy, while modular structure is optimally positioned in 3D exploiting mathematical properties of platonic solids. NeuroCave provides new functionality to support a range of analysis tasks not available in other visualization software platforms., Competing Interests: Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2018
- Full Text
- View/download PDF
18. From Default Mode Network to the Basal Configuration: Sex Differences in the Resting-State Brain Connectivity as a Function of Age and Their Clinical Correlates.
- Author
-
Conrin SD, Zhan L, Morrissey ZD, Xing M, Forbes A, Maki P, Milad MR, Ajilore O, Langenecker SA, and Leow AD
- Abstract
Connectomics is a framework that models brain structure and function interconnectivity as a network, rather than narrowly focusing on select regions-of-interest. MRI-derived connectomes can be structural, usually based on diffusion-weighted MR imaging, or functional, usually formed by examining fMRI blood-oxygen-level-dependent (BOLD) signal correlations. Recently, we developed a novel method for assessing the hierarchical modularity of functional brain networks-the probability associated community estimation (PACE). PACE uniquely permits a dual formulation, thus yielding equivalent connectome modular structure regardless of whether positive or negative edges are considered. This method was rigorously validated using the 1,000 functional connectomes project data set (F1000, RRID:SCR_005361) (1) and the Human Connectome Project (HCP, RRID:SCR_006942) (2, 3) and we reported novel sex differences in resting-state connectivity not previously reported. (4) This study further examines sex differences in regard to hierarchical modularity as a function of age and clinical correlates, with findings supporting a basal configuration framework as a more nuanced and dynamic way of conceptualizing the resting-state connectome that is modulated by both age and sex. Our results showed that differences in connectivity between men and women in the 22-25 age range were not significantly different. However, these same non-significant differences attained significance in both the 26-30 age group ( p = 0.003) and the 31-35 age group ( p < 0.001). At the most global level, areas of diverging sex difference include parts of the prefrontal cortex and the temporal lobe, amygdala, hippocampus, inferior parietal lobule, posterior cingulate, and precuneus. Further, we identified statistically different self-reported summary scores of inattention, hyperactivity, and anxiety problems between men and women. These self-reports additionally divergently interact with age and the basal configuration between sexes.
- Published
- 2018
- Full Text
- View/download PDF
19. Risk of Diabetes Hospitalization or Diabetes Drug Intensification in Patients With Depression and Diabetes Using Second-Generation Antipsychotics Compared to Other Depression Therapies.
- Author
-
Xing S, Kim S, Schumock GT, Touchette DR, Calip GS, Leow AD, and Lee TA
- Subjects
- Adolescent, Adult, Bupropion adverse effects, Comorbidity, Depressive Disorder epidemiology, Female, Hospitalization statistics & numerical data, Humans, Male, Mianserin adverse effects, Mianserin analogs & derivatives, Middle Aged, Mirtazapine, Proportional Hazards Models, Quetiapine Fumarate adverse effects, Retrospective Studies, Young Adult, Antidepressive Agents, Second-Generation adverse effects, Antidepressive Agents, Tricyclic adverse effects, Antipsychotic Agents adverse effects, Depressive Disorder drug therapy, Diabetes Mellitus, Type 2 chemically induced, Diabetes Mellitus, Type 2 drug therapy, Diabetes Mellitus, Type 2 epidemiology
- Abstract
Objective: Use of second-generation antipsychotics (SGAs) for treatment of depression has increased, and patients with depression and comorbid diabetes or cardiovascular disease are more likely to use SGAs than those without these conditions. We compared SGA and non-SGA depression pharmacotherapies on the risk of diabetes hospitalization or treatment intensification in adults with depression and preexisting diabetes., Methods: This was a retrospective cohort study of US commercially insured adults (2009-2015 Truven MarketScan Commercial Claims and Encounters Database) aged 18-64 years old with type 2 diabetes mellitus and unipolar depression previously treated with a selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitor. New users of SGAs versus non-SGAs, as well as specific treatments (aripiprazole, quetiapine, bupropion, mirtazapine, and tricyclic antidepressants [TCAs]) were matched on class/medication-specific high-dimensional propensity score. Cox proportional hazard models were used to compare the risk of diabetes-related hospitalization or treatment intensification., Results: We identified 6,625 SGA (aripiprazole = 3,461; quetiapine = 1,977; other = 1,187) and 23,921 non-SGA patients for inclusion (bupropion = 15,511; mirtazapine = 1,837; TCAs = 5,989; other = 584) with a mean age of 51 years. In the matched cohort, the rate of diabetes-related hospitalization or drug intensification was 47.9 per 100 person-years in the SGA group and 43.5 per 100 person-years in the non-SGA group (adjusted hazard ratio [aHR] = 1.03; 95% CI, 0.96-1.11). When comparing treatment subgroups, the risk of events was lower for bupropion versus TCAs (aHR = 0.85; 95% CI, 0.76-0.98), quetiapine versus mirtazapine (aHR = 0.82; 95% CI, 0.67-0.99), and quetiapine versus TCAs (aHR = 0.84; 95% CI, 0.72-0.98). For other comparisons, differences were small and not statistically significant., Conclusions: While drug-specific effects on risk of diabetes hospitalization or treatment intensification most likely guide clinical decision making, we observed only modest differences in risk. The overall impact of SGAs on diabetes control depends not only on direct effects on glucose metabolism but also on effectiveness of depression symptom relief. Future studies evaluating other diabetes outcomes (glycosylated hemoglobin, diabetes complications) are needed., (© Copyright 2018 Physicians Postgraduate Press, Inc.)
- Published
- 2018
- Full Text
- View/download PDF
20. The impact of depression medications on oral antidiabetic drug adherence in patients with diabetes and depression.
- Author
-
Xing S, Calip GS, Leow AD, Kim S, Schumock GT, Touchette DR, and Lee TA
- Subjects
- Administration, Oral, Adolescent, Adult, Depression complications, Depression drug therapy, Depression epidemiology, Depressive Disorder, Major complications, Depressive Disorder, Major epidemiology, Diabetes Mellitus, Type 2 complications, Diabetes Mellitus, Type 2 epidemiology, Female, Humans, Male, Middle Aged, Retrospective Studies, United States epidemiology, Young Adult, Antidepressive Agents therapeutic use, Depressive Disorder, Major drug therapy, Diabetes Mellitus, Type 2 drug therapy, Hypoglycemic Agents administration & dosage, Medication Adherence statistics & numerical data
- Abstract
Aims: To compare adherence and persistence to oral antidiabetic drugs (OAD) between patients who are new users of second generation antipsychotics (SGA) versus new users of other depression therapies in adults with type 2 diabetes mellitus (T2DM) and major depressive disorder (MDD)., Methods: Adults 18-64 years with previously-treated T2DM and MDD (past OAD and SSRI/SNRI use) who are new users of SGA or non-SGA therapies (bupropion, lithium, mirtazapine, thyroid hormone, tricyclic antidepressant) were identified in the 2009-2015 MarketScan® Commercial Claims and Encounters database. Multivariate regression models were used to determine the odds of a ≥10% decline in OAD adherence over 180- and 365-days, and time to OAD discontinuation, adjusting for differences between groups., Results: A total of 8664 (21.5% SGA), 8311 (22.1% SGA), and 17,524 (21.3% SGA) patients met inclusion criteria for the 180-day adherence, 365-day adherence, and persistence cohorts, respectively. Over 180-days, 16.6% of SGA and 13.3% of non-SGA initiators had a ≥10% decline in OAD adherence (adjusted odds ratio [OR] = 1.41, 95% CI 1.21-1.63). Over 365-days, 22.3% of SGA and 18.9% of non-SGA initiators had a ≥ 10% decline (OR = 1.34, 95% CI 1.17-1.53). Time to OAD discontinuation was similar between groups (adjusted hazard ratio = 1.03, 95% CI 0.94-1.12)., Conclusion: Use of SGA was associated with a 1.3-1.4 times higher odds of a ≥10% decline in OAD adherence. Adherence to OAD is critical for optimal diabetes control and reductions in this magnitude may impact A1C. Close monitoring of OAD adherence after SGA initiation is warranted., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
21. Baseline connectome modular abnormalities in the childhood phase of a longitudinal study on individuals with chromosome 22q11.2 deletion syndrome.
- Author
-
Zhan L, Jenkins LM, Zhang A, Conte G, Forbes A, Harvey D, Angkustsiri K, Goodrich-Hunsaker NJ, Durdle C, Lee A, Schumann C, Carmichael O, Kalish K, Leow AD, and Simon TJ
- Subjects
- Adolescent, Brain diagnostic imaging, Brain growth & development, Child, Cluster Analysis, DiGeorge Syndrome diagnostic imaging, Female, Functional Laterality, Humans, Longitudinal Studies, Male, Neural Pathways diagnostic imaging, Neural Pathways physiopathology, Brain physiopathology, Connectome methods, DiGeorge Syndrome physiopathology
- Abstract
Occurring in at least 1 in 3,000 live births, chromosome 22q11.2 deletion syndrome (22q11DS) produces a complex phenotype that includes a constellation of medical complications such as congenital cardiac defects, immune deficiency, velopharyngeal dysfunction, and characteristic facial dysmorphic features. There is also an increased incidence of psychiatric diagnosis, especially intellectual disability and ADHD in childhood, lifelong anxiety, and a strikingly high rate of schizophrenia spectrum disorders, which occur in around 30% of adults with 22q11DS. Using innovative computational connectomics, we studied how 22q11DS affects high-level network signatures of hierarchical modularity and its intrinsic geometry in 55 children with confirmed 22q11DS and 27 Typically Developing (TD) children. Results identified 3 subgroups within our 22q11DS sample using a K-means clustering approach based on several midline structural measures-of-interests. Each subgroup exhibited distinct patterns of connectome abnormalities. Subtype 1, containing individuals with generally healthy-looking brains, exhibited no significant differences in either modularity or intrinsic geometry when compared with TD. By contrast, the more anomalous 22q11DS Subtypes 2 and 3 brains revealed significant modular differences in the right hemisphere, while Subtype 3 (the most anomalous anatomy) further exhibited significantly abnormal connectome intrinsic geometry in the form of left-right temporal disintegration. Taken together, our findings supported an overall picture of (a) anterior-posteriorly differential interlobar frontotemporal/frontoparietal dysconnectivity in Subtypes 2 and 3 and (b) differential intralobar dysconnectivity in Subtype 3. Our ongoing studies are focusing on whether these subtypes and their connnectome signatures might be valid biomarkers for predicting the degree of psychosis-proneness risk found in 22q11DS. Hum Brain Mapp 39:232-248, 2018. © 2017 Wiley Periodicals, Inc., (© 2017 Wiley Periodicals, Inc.)
- Published
- 2018
- Full Text
- View/download PDF
22. Fractional anisotropy derived from the diffusion tensor distribution function boosts power to detect Alzheimer's disease deficits.
- Author
-
Nir TM, Jahanshad N, Villalon-Reina JE, Isaev D, Zavaliangos-Petropulu A, Zhan L, Leow AD, Jack CR Jr, Weiner MW, and Thompson PM
- Subjects
- Aged, Brain diagnostic imaging, Brain Mapping, Cognition Disorders diagnostic imaging, Female, Hippocampus diagnostic imaging, Humans, Image Processing, Computer-Assisted, Longitudinal Studies, Male, Memory, Memory Disorders diagnostic imaging, Middle Aged, Reproducibility of Results, White Matter diagnostic imaging, Alzheimer Disease diagnostic imaging, Anisotropy, Diffusion Magnetic Resonance Imaging
- Abstract
Purpose: In diffusion MRI (dMRI), fractional anisotropy derived from the single-tensor model (FA
DTI ) is the most widely used metric to characterize white matter (WM) microarchitecture, despite known limitations in regions with crossing fibers. Due to time constraints when scanning patients in clinical settings, high angular resolution diffusion imaging acquisition protocols, often used to overcome these limitations, are still rare in clinical population studies. However, the tensor distribution function (TDF) may be used to model multiple underlying fibers by representing the diffusion profile as a probabilistic mixture of tensors., Methods: We compared the ability of standard FADTI and TDF-derived FA (FATDF ), calculated from a range of dMRI angular resolutions (41, 30, 15, and 7 gradient directions), to profile WM deficits in 251 individuals from the Alzheimer's Disease Neuroimaging Initiative and to detect associations with 1) Alzheimer's disease diagnosis, 2) Clinical Dementia Rating scores, and 3) average hippocampal volume., Results: Across angular resolutions and statistical tests, FATDF showed larger effect sizes than FADTI , particularly in regions preferentially affected by Alzheimer's disease, and was less susceptible to crossing fiber anomalies., Conclusion: The TDF "corrected" form of FA may be a more sensitive and accurate alternative to the commonly used FADTI , even in clinical quality dMRI data. Magn Reson Med 78:2322-2333, 2017. © 2017 International Society for Magnetic Resonance in Medicine., (© 2017 International Society for Magnetic Resonance in Medicine.)- Published
- 2017
- Full Text
- View/download PDF
23. The significance of negative correlations in brain connectivity.
- Author
-
Zhan L, Jenkins LM, Wolfson OE, GadElkarim JJ, Nocito K, Thompson PM, Ajilore OA, Chung MK, and Leow AD
- Subjects
- Cerebrovascular Circulation physiology, Computer Simulation, Female, Humans, Male, Models, Neurological, Neural Pathways diagnostic imaging, Neural Pathways physiology, Oxygen blood, Rest, Sex Characteristics, Brain diagnostic imaging, Brain physiology, Connectome methods, Magnetic Resonance Imaging methods
- Abstract
Understanding the modularity of functional magnetic resonance imaging (fMRI)-derived brain networks or "connectomes" can inform the study of brain function organization. However, fMRI connectomes additionally involve negative edges, which may not be optimally accounted for by existing approaches to modularity that variably threshold, binarize, or arbitrarily weight these connections. Consequently, many existing Q maximization-based modularity algorithms yield variable modular structures. Here, we present an alternative complementary approach that exploits how frequent the blood-oxygen-level-dependent (BOLD) signal correlation between two nodes is negative. We validated this novel probability-based modularity approach on two independent publicly-available resting-state connectome data sets (the Human Connectome Project [HCP] and the 1,000 functional connectomes) and demonstrated that negative correlations alone are sufficient in understanding resting-state modularity. In fact, this approach (a) permits a dual formulation, leading to equivalent solutions regardless of whether one considers positive or negative edges; (b) is theoretically linked to the Ising model defined on the connectome, thus yielding modularity result that maximizes data likelihood. Additionally, we were able to detect novel and consistent sex differences in modularity in both data sets. As data sets like HCP become widely available for analysis by the neuroscience community at large, alternative and perhaps more advantageous computational tools to understand the neurobiological information of negative edges in fMRI connectomes are increasingly important., (© 2017 Wiley Periodicals, Inc.)
- Published
- 2017
- Full Text
- View/download PDF
24. Shared white matter alterations across emotional disorders: A voxel-based meta-analysis of fractional anisotropy.
- Author
-
Jenkins LM, Barba A, Campbell M, Lamar M, Shankman SA, Leow AD, Ajilore O, and Langenecker SA
- Subjects
- Humans, Bipolar Disorder diagnostic imaging, Depressive Disorder, Major diagnostic imaging, Diffusion Tensor Imaging statistics & numerical data, Obsessive-Compulsive Disorder diagnostic imaging, Phobia, Social diagnostic imaging, Stress Disorders, Post-Traumatic diagnostic imaging, White Matter diagnostic imaging
- Abstract
Background: White matter (WM) integrity may represent a shared biomarker for emotional disorders (ED). Aims: To identify transdiagnostic biomarkers of reduced WM by meta-analysis of findings across multiple EDs., Method: Web of Science was searched systematically for studies of whole brain analysis of fractional anisotropy (FA) in adults with major depressive disorder, bipolar disorder, social anxiety disorder, obsessive-compulsive disorder or posttraumatic stress disorder compared with a healthy control (HC) group. Peak MNI coordinates were extracted from 37 studies of voxel-based analysis (892 HC and 962 with ED) and meta-analyzed using seed-based d Mapping (SDM) Version 4.31. Separate meta-analyses were also conducted for each disorder., Results: In the transdiagnostic meta-analysis, reduced FA was identified in ED studies compared to HCs in the left inferior fronto-occipital fasciculus, forceps minor, uncinate fasciculus, anterior thalamic radiation, superior corona radiata, bilateral superior longitudinal fasciculi, and cerebellum. Disorder-specific meta-analyses revealed the OCD group had the most similarities in reduced FA to other EDs, with every cluster of reduced FA overlapping with at least one other diagnosis. The PTSD group was the most distinct, with no clusters of reduced FA overlapping with any other diagnosis. The BD group were the only disorder to show increased FA in any region, and showed a more bilateral pattern of WM changes, compared to the other groups which tended to demonstrate a left lateralized pattern of FA reductions., Conclusions: Distinct diagnostic categories of ED show commonalities in WM tracts with reduced FA when compared to HC, which links brain networks involved in cognitive and affective processing. This meta-analysis facilitates an increased understanding of the biological markers that are shared by these ED.
- Published
- 2016
- Full Text
- View/download PDF
25. MRI-based brain atrophy rates in ADNI phase 2: acceleration and enrichment considerations for clinical trials.
- Author
-
Hua X, Ching CRK, Mezher A, Gutman BA, Hibar DP, Bhatt P, Leow AD, Jack CR Jr, Bernstein MA, Weiner MW, and Thompson PM
- Subjects
- Aged, Aged, 80 and over, Alzheimer Disease drug therapy, Alzheimer Disease genetics, Amyloidogenic Proteins, Apolipoproteins E, Atrophy, Clinical Trials as Topic, Cognition Disorders drug therapy, Cognition Disorders genetics, Cognition Disorders pathology, Cohort Studies, Female, Humans, Male, Middle Aged, Risk, Alzheimer Disease pathology, Brain pathology, Diffusion Magnetic Resonance Imaging methods, Neuroimaging methods
- Abstract
The goal of this work was to assess statistical power to detect treatment effects in Alzheimer's disease (AD) clinical trials using magnetic resonance imaging (MRI)-derived brain biomarkers. We used unbiased tensor-based morphometry (TBM) to analyze n = 5,738 scans, from Alzheimer's Disease Neuroimaging Initiative 2 participants scanned with both accelerated and nonaccelerated T1-weighted MRI at 3T. The study cohort included 198 healthy controls, 111 participants with significant memory complaint, 182 with early mild cognitive impairment (EMCI) and 177 late mild cognitive impairment (LMCI), and 155 AD patients, scanned at screening and 3, 6, 12, and 24 months. The statistical power to track brain change in TBM-based imaging biomarkers depends on the interscan interval, disease stage, and methods used to extract numerical summaries. To achieve reasonable sample size estimates for potential clinical trials, the minimal scan interval was 6 months for LMCI and AD and 12 months for EMCI. TBM-based imaging biomarkers were not sensitive to MRI scan acceleration, which gave results comparable with nonaccelerated sequences. ApoE status and baseline amyloid-beta positron emission tomography data improved statistical power. Among healthy, EMCI, and LMCI participants, sample size requirements were significantly lower in the amyloid+/ApoE4+ group than for the amyloid-/ApoE4- group. ApoE4 strongly predicted atrophy rates across brain regions most affected by AD, but the remaining 9 of the top 10 AD risk genes offered no added predictive value in this cohort., (Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
26. The intrinsic geometry of the human brain connectome.
- Author
-
Ye AQ, Ajilore OA, Conte G, GadElkarim J, Thomas-Ramos G, Zhan L, Yang S, Kumar A, Magin RL, G Forbes A, and Leow AD
- Abstract
This paper describes novel methods for constructing the intrinsic geometry of the human brain connectome using dimensionality-reduction techniques. We posit that the high-dimensional, complex geometry that represents this intrinsic topology can be mathematically embedded into lower dimensions using coupling patterns encoded in the corresponding brain connectivity graphs. We tested both linear and nonlinear dimensionality-reduction techniques using the diffusion-weighted structural connectome data acquired from a sample of healthy subjects. Results supported the nonlinearity of brain connectivity data, as linear reduction techniques such as the multidimensional scaling yielded inferior lower-dimensional embeddings. To further validate our results, we demonstrated that for tractography-derived structural connectome more influential regions such as rich-club members of the brain are more centrally mapped or embedded. Further, abnormal brain connectivity can be visually understood by inspecting the altered geometry of these three-dimensional (3D) embeddings that represent the topology of the human brain, as illustrated using simulated lesion studies of both targeted and random removal. Last, in order to visualize brain's intrinsic topology we have developed software that is compatible with virtual reality technologies, thus allowing researchers to collaboratively and interactively explore and manipulate brain connectome data.
- Published
- 2015
- Full Text
- View/download PDF
27. Investigating brain community structure abnormalities in bipolar disorder using path length associated community estimation.
- Author
-
Gadelkarim JJ, Ajilore O, Schonfeld D, Zhan L, Thompson PM, Feusner JD, Kumar A, Altshuler LL, and Leow AD
- Subjects
- Adult, Brain Mapping, Female, Functional Laterality, Humans, Male, Middle Aged, Models, Neurological, Bipolar Disorder complications, Bipolar Disorder pathology, Brain pathology, Nerve Net physiology, Neural Pathways pathology
- Abstract
In this article, we present path length associated community estimation (PLACE), a comprehensive framework for studying node-level community structure. Instead of the well-known Q modularity metric, PLACE utilizes a novel metric, Ψ(PL), which measures the difference between intercommunity versus intracommunity path lengths. We compared community structures in human healthy brain networks generated using these two metrics and argued that Ψ(PL) may have theoretical advantages. PLACE consists of the following: (1) extracting community structure using top-down hierarchical binary trees, where a branch at each bifurcation denotes a collection of nodes that form a community at that level, (2) constructing and assessing mean group community structure, and (3) detecting node-level changes in community between groups. We applied PLACE and investigated the structural brain networks obtained from a sample of 25 euthymic bipolar I subjects versus 25 gender- and age-matched healthy controls. Results showed community structural differences in posterior default mode network regions, with the bipolar group exhibiting left-right decoupling., (Copyright © 2013 Wiley Periodicals, Inc.)
- Published
- 2014
- Full Text
- View/download PDF
28. Neuroanatomical correlates of emotional blunting in behavioral variant frontotemporal dementia and early-onset Alzheimer's disease.
- Author
-
Lee GJ, Lu PH, Mather MJ, Shapira J, Jimenez E, Leow AD, Thompson PM, and Mendez MF
- Subjects
- Adult, Aged, Female, Humans, Image Processing, Computer-Assisted, Magnetic Resonance Imaging, Male, Middle Aged, Psychiatric Status Rating Scales, Statistics as Topic, Alzheimer Disease complications, Alzheimer Disease pathology, Behavioral Symptoms etiology, Frontotemporal Dementia complications, Frontotemporal Dementia pathology, Mood Disorders etiology
- Abstract
Background: Emotional blunting is a characteristic feature of behavioral variant frontotemporal dementia (bvFTD) and can help discriminate between patients with bvFTD and other forms of younger-onset dementia., Objective: We compared the presence of emotional blunting symptoms in patients with bvFTD and early-onset Alzheimer's disease (AD), and investigated the neuroanatomical associations between emotional blunting and regional brain volume., Methods: Twenty-five individuals with bvFTD (n = 11) and early-onset AD (n = 14) underwent magnetic resonance imaging (MRI) and were rated on symptoms of emotional blunting using the Scale for Emotional Blunting (SEB). The two groups were compared on SEB ratings and MRI-derived brain volume using tensor-based morphometry. Voxel-wise linear regression was performed to determine neuroanatomical correlates of SEB scores., Results: The bvFTD group had significantly higher SEB scores compared to the AD group. On MRI, bvFTD patients had smaller bilateral frontal lobe volume compared to AD patients, while AD patients had smaller bilateral temporal and left parietal volume than bvFTD patients. In bvFTD, SEB ratings were strongly correlated with right anterior temporal volume, while the association between SEB and the right orbitofrontal cortex was non-significant., Conclusions: Symptoms of emotional blunting were more prevalent in bvFTD than early-onset AD patients. These symptoms were particularly associated with right-sided atrophy, with significant involvement of the right anterior temporal region. Based on these findings, the SEB appears to measure symptoms of emotional blunting that are localized to the right anterior temporal lobe.
- Published
- 2014
- Full Text
- View/download PDF
29. Angular versus spatial resolution trade-offs for diffusion imaging under time constraints.
- Author
-
Zhan L, Jahanshad N, Ennis DB, Jin Y, Bernstein MA, Borowski BJ, Jack CR Jr, Toga AW, Leow AD, and Thompson PM
- Subjects
- Adult, Algorithms, Artifacts, Brain Mapping statistics & numerical data, Computer Simulation, Diffusion Magnetic Resonance Imaging statistics & numerical data, Echo-Planar Imaging methods, Female, Head Movements, Humans, Male, Models, Neurological, Nerve Fibers physiology, Phantoms, Imaging, Reference Values, Reproducibility of Results, Research Design, Signal-To-Noise Ratio, Time Factors, Brain Mapping methods, Diffusion Magnetic Resonance Imaging methods, Image Processing, Computer-Assisted methods
- Abstract
Diffusion weighted magnetic resonance imaging (DW-MRI) are now widely used to assess brain integrity in clinical populations. The growing interest in mapping brain connectivity has made it vital to consider what scanning parameters affect the accuracy, stability, and signal-to-noise of diffusion measures. Trade-offs between scan parameters can only be optimized if their effects on various commonly-derived measures are better understood. To explore angular versus spatial resolution trade-offs in standard tensor-derived measures, and in measures that use the full angular information in diffusion signal, we scanned eight subjects twice, 2 weeks apart, using three protocols that took the same amount of time (7 min). Scans with 3.0, 2.7, 2.5 mm isotropic voxels were collected using 48, 41, and 37 diffusion-sensitized gradients to equalize scan times. A specially designed DTI phantom was also scanned with the same protocols, and different b-values. We assessed how several diffusion measures including fractional anisotropy (FA), mean diffusivity (MD), and the full 3D orientation distribution function (ODF) depended on the spatial/angular resolution and the SNR. We also created maps of stability over time in the FA, MD, ODF, skeleton FA of 14 TBSS-derived ROIs, and an information uncertainty index derived from the tensor distribution function, which models the signal using a continuous mixture of tensors. In scans of the same duration, higher angular resolution and larger voxels boosted SNR and improved stability over time. The increased partial voluming in large voxels also led to bias in estimating FA, but this was partially addressed by using "beyond-tensor" models of diffusion., (Copyright © 2012 Wiley Periodicals, Inc.)
- Published
- 2013
- Full Text
- View/download PDF
30. DTI tractography and white matter fiber tract characteristics in euthymic bipolar I patients and healthy control subjects.
- Author
-
Torgerson CM, Irimia A, Leow AD, Bartzokis G, Moody TD, Jennings RG, Alger JR, Van Horn JD, and Altshuler LL
- Subjects
- Adult, Anisotropy, Bipolar Disorder drug therapy, Female, Humans, Male, Middle Aged, Mood Disorders drug therapy, Mood Disorders pathology, Psychotropic Drugs therapeutic use, Bipolar Disorder pathology, Corpus Callosum pathology, Diffusion Tensor Imaging, Nerve Fibers, Myelinated pathology
- Abstract
With the introduction of diffusion tensor imaging (DTI), structural differences in white matter (WM) architecture between psychiatric populations and healthy controls can be systematically observed and measured. In particular, DTI-tractography can be used to assess WM characteristics over the entire extent of WM tracts and aggregated fiber bundles. Using 64-direction DTI scanning in 27 participants with bipolar disorder (BD) and 26 age-and-gender-matched healthy control subjects, we compared relative length, density, and fractional anisotrophy (FA) of WM tracts involved in emotion regulation or theorized to be important neural components in BD neuropathology. We interactively isolated 22 known white matter tracts using region-of-interest placement (TrackVis software program) and then computed relative tract length, density, and integrity. BD subjects demonstrated significantly shorter WM tracts in the genu, body and splenium of the corpus callosum compared to healthy controls. Additionally, bipolar subjects exhibited reduced fiber density in the genu and body of the corpus callosum, and in the inferior longitudinal fasciculus bilaterally. In the left uncinate fasciculus, however, BD subjects exhibited significantly greater fiber density than healthy controls. There were no significant differences between groups in WM tract FA for those tracts that began and ended in the brain. The significance of differences in tract length and fiber density in BD is discussed.
- Published
- 2013
- Full Text
- View/download PDF
31. White matter microstructure in body dysmorphic disorder and its clinical correlates.
- Author
-
Feusner JD, Arienzo D, Li W, Zhan L, Gadelkarim J, Thompson PM, and Leow AD
- Subjects
- Adult, Anisotropy, Body Dysmorphic Disorders diagnosis, Case-Control Studies, Comprehension, Female, Humans, Male, Neural Pathways pathology, Severity of Illness Index, Body Dysmorphic Disorders pathology, Nerve Fibers, Myelinated pathology, Neuroimaging
- Abstract
Body dysmorphic disorder (BDD) is characterized by an often-delusional preoccupation with misperceived defects of appearance, causing significant distress and disability. Although previous studies have found functional abnormalities in visual processing, frontostriatal, and limbic systems, no study to date has investigated the microstructure of white matter connecting these systems in BDD. Participants comprised 14 medication-free individuals with BDD and 16 healthy controls who were scanned using diffusion-weighted magnetic resonance imaging (MRI). We utilized probabilistic tractography to reconstruct tracts of interest, and tract-based spatial statistics to investigate whole brain white matter. To estimate white matter microstructure, we used fractional anisotropy (FA), mean diffusivity (MD), and linear and planar anisotropy (c(l) and c(p)). We correlated diffusion measures with clinical measures of symptom severity and poor insight/delusionality. Poor insight negatively correlated with FA and c(l) and positively correlated with MD in the inferior longitudinal fasciculus (ILF) and the forceps major (FM). FA and c(l) were lower in the ILF and the inferior fronto-occipital fasciculus and higher in the FM in the BDD group, but differences were nonsignificant. This is the first diffusion-weighted MR investigation of white matter in BDD. Results suggest a relationship between impairments in insight, a clinically important phenotype, and fiber disorganization in tracts connecting visual with emotion/memory processing systems., (Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
32. Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials.
- Author
-
Hua X, Hibar DP, Ching CR, Boyle CP, Rajagopalan P, Gutman BA, Leow AD, Toga AW, Jack CR Jr, Harvey D, Weiner MW, and Thompson PM
- Subjects
- Aged, Alzheimer Disease genetics, Apolipoproteins E genetics, Atrophy, Clinical Trials as Topic, Data Interpretation, Statistical, Diffusion Tensor Imaging instrumentation, Female, Humans, Male, Prospective Studies, Research Design standards, Alzheimer Disease pathology, Brain pathology, Cognitive Dysfunction pathology, Diffusion Tensor Imaging methods
- Abstract
Various neuroimaging measures are being evaluated for tracking Alzheimer's disease (AD) progression in therapeutic trials, including measures of structural brain change based on repeated scanning of patients with magnetic resonance imaging (MRI). Methods to compute brain change must be robust to scan quality. Biases may arise if any scans are thrown out, as this can lead to the true changes being overestimated or underestimated. Here we analyzed the full MRI dataset from the first phase of Alzheimer's Disease Neuroimaging Initiative (ADNI-1) from the first phase of Alzheimer's Disease Neuroimaging Initiative (ADNI-1) and assessed several sources of bias that can arise when tracking brain changes with structural brain imaging methods, as part of a pipeline for tensor-based morphometry (TBM). In all healthy subjects who completed MRI scanning at screening, 6, 12, and 24months, brain atrophy was essentially linear with no detectable bias in longitudinal measures. In power analyses for clinical trials based on these change measures, only 39AD patients and 95 mild cognitive impairment (MCI) subjects were needed for a 24-month trial to detect a 25% reduction in the average rate of change using a two-sided test (α=0.05, power=80%). Further sample size reductions were achieved by stratifying the data into Apolipoprotein E (ApoE) ε4 carriers versus non-carriers. We show how selective data exclusion affects sample size estimates, motivating an objective comparison of different analysis techniques based on statistical power and robustness. TBM is an unbiased, robust, high-throughput imaging surrogate marker for large, multi-site neuroimaging studies and clinical trials of AD and MCI., (Copyright © 2012 Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
33. Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations.
- Author
-
Lee GJ, Lu PH, Medina LD, Rodriguez-Agudelo Y, Melchor S, Coppola G, Braskie MN, Hua X, Apostolova LG, Leow AD, Thompson PM, and Ringman JM
- Subjects
- Adult, Alzheimer Disease diagnosis, Alzheimer Disease genetics, Alzheimer Disease psychology, Amyloid beta-Protein Precursor genetics, Atrophy pathology, Cognition Disorders genetics, Cognition Disorders psychology, Female, Humans, Magnetic Resonance Imaging methods, Magnetic Resonance Imaging psychology, Male, Mutation, Neuroimaging methods, Neuropsychological Tests statistics & numerical data, Organ Size, Presenilin-1 genetics, Alzheimer Disease pathology, Brain pathology, Cognition Disorders pathology, Heterozygote, Neuroimaging psychology
- Abstract
Background: Mutations in the presenilin (PSEN1, PSEN2) and amyloid precursor protein (APP) genes cause familial Alzheimer's disease (FAD) in a nearly fully penetrant, autosomal dominant manner, providing a unique opportunity to study presymptomatic individuals who can be predicted to develop Alzheimer's disease (AD) with essentially 100% certainty. Using tensor-based morphometry (TBM), we examined brain volume differences between presymptomatic and symptomatic FAD mutation carriers and non-carrier (NC) relatives., Methods: Twenty-five mutation carriers and 10 NC relatives underwent brain MRI and clinical assessment. Four mutation carriers had dementia (MUT-Dem), 12 had amnestic mild cognitive impairment (MUT-aMCI) and nine were cognitively normal (MUT-Norm). TBM brain volume maps of MUT-Norm, MUT-aMCI and MUT-Dem subjects were compared to NC subjects., Results: MUT-Norm subjects exhibited significantly smaller volumes in the thalamus, caudate and putamen. MUT-aMCI subjects had smaller volumes in the thalamus, splenium and pons, but not in the caudate or putamen. MUT-Dem subjects demonstrated smaller volumes in temporal, parietal and left frontal regions. As non-demented carriers approached the expected age of dementia diagnosis, this was associated with larger ventricular and caudate volumes and a trend towards smaller temporal lobe volume., Conclusions: Cognitively intact FAD mutation carriers had lower thalamic, caudate and putamen volumes, and we found preliminary evidence for increasing caudate size during the predementia stage. These regions may be affected earliest during prodromal stages of FAD, while cortical atrophy may occur in later stages, when carriers show cognitive deficits. Further studies of this population will help us understand the progression of neurobiological changes in AD.
- Published
- 2013
- Full Text
- View/download PDF
34. Brain growth rate abnormalities visualized in adolescents with autism.
- Author
-
Hua X, Thompson PM, Leow AD, Madsen SK, Caplan R, Alger JR, O'Neill J, Joshi K, Smalley SL, Toga AW, and Levitt JG
- Subjects
- Adolescent, Aging physiology, Algorithms, Autistic Disorder therapy, Brain Mapping, Child, Data Interpretation, Statistical, Diagnostic and Statistical Manual of Mental Disorders, Female, Gyrus Cinguli growth & development, Gyrus Cinguli pathology, Humans, Image Processing, Computer-Assisted, Intelligence physiology, Intelligence Tests, Magnetic Resonance Imaging, Male, Neuropsychological Tests, Putamen growth & development, Putamen pathology, Wechsler Scales, Autistic Disorder pathology, Brain growth & development, Brain pathology
- Abstract
Autism spectrum disorder is a heterogeneous disorder of brain development with wide ranging cognitive deficits. Typically diagnosed before age 3, autism spectrum disorder is behaviorally defined but patients are thought to have protracted alterations in brain maturation. With longitudinal magnetic resonance imaging (MRI), we mapped an anomalous developmental trajectory of the brains of autistic compared with those of typically developing children and adolescents. Using tensor-based morphometry, we created 3D maps visualizing regional tissue growth rates based on longitudinal brain MRI scans of 13 autistic and seven typically developing boys (mean age/interscan interval: autism 12.0 ± 2.3 years/2.9 ± 0.9 years; control 12.3 ± 2.4/2.8 ± 0.8). The typically developing boys demonstrated strong whole brain white matter growth during this period, but the autistic boys showed abnormally slowed white matter development (P = 0.03, corrected), especially in the parietal (P = 0.008), temporal (P = 0.03), and occipital lobes (P = 0.02). We also visualized abnormal overgrowth in autism in gray matter structures such as the putamen and anterior cingulate cortex. Our findings reveal aberrant growth rates in brain regions implicated in social impairment, communication deficits and repetitive behaviors in autism, suggesting that growth rate abnormalities persist into adolescence. Tensor-based morphometry revealed persisting growth rate anomalies long after diagnosis, which has implications for evaluation of therapeutic effects., (Copyright © 2011 Wiley Periodicals, Inc.)
- Published
- 2013
- Full Text
- View/download PDF
35. Patterns of brain atrophy in clinical variants of frontotemporal lobar degeneration.
- Author
-
Lu PH, Mendez MF, Lee GJ, Leow AD, Lee HW, Shapira J, Jimenez E, Boeve BB, Caselli RJ, Graff-Radford NR, Jack CR, Kramer JH, Miller BL, Bartzokis G, Thompson PM, and Knopman DS
- Subjects
- Aged, Algorithms, Atrophy, Behavior physiology, Cognition physiology, Diffusion Tensor Imaging, Disease Progression, Executive Function, Female, Humans, Image Processing, Computer-Assisted, Language, Longitudinal Studies, Magnetic Resonance Imaging, Male, Middle Aged, Neuropsychological Tests, Psychomotor Performance physiology, Brain pathology, Frontotemporal Lobar Degeneration pathology
- Abstract
Background/aims: The clinical syndromes of frontotemporal lobar degeneration include behavioral variant frontotemporal dementia (bvFTD) and semantic (SV-PPA) and nonfluent variants (NF-PPA) of primary progressive aphasia. Using magnetic resonance imaging (MRI), tensor-based morphometry (TBM) was used to determine distinct patterns of atrophy between these three clinical groups., Methods: Twenty-seven participants diagnosed with bvFTD, 16 with SV-PPA, and 19 with NF-PPA received baseline and follow-up MRI scans approximately 1 year apart. TBM was used to create three-dimensional Jacobian maps of local brain atrophy rates for individual subjects., Results: Regional analyses were performed on the three-dimensional maps and direct comparisons between groups (corrected for multiple comparisons using permutation tests) revealed significantly greater frontal lobe and frontal white matter atrophy in the bvFTD relative to the SV-PPA group (p < 0.005). The SV-PPA subjects exhibited significantly greater atrophy than the bvFTD in the fusiform gyrus (p = 0.007). The NF-PPA group showed significantly more atrophy in the parietal lobes relative to both bvFTD and SV-PPA groups (p < 0.05). Percent volume change in ventromedial prefrontal cortex was significantly associated with baseline behavioral symptomatology., Conclusion: The bvFTD, SV-PPA, and NF-PPA groups displayed distinct patterns of progressive atrophy over a 1-year period that correspond well to the behavioral disturbances characteristic of the clinical syndromes. More specifically, the bvFTD group showed significant white matter contraction and presence of behavioral symptoms at baseline predicted significant volume loss of the ventromedial prefrontal cortex., (Copyright © 2013 S. Karger AG, Basel.)
- Published
- 2013
- Full Text
- View/download PDF
36. Multi-resolutional brain network filtering and analysis via wavelets on non-Euclidean space.
- Author
-
Kim WH, Adluru N, Chung MK, Charchut S, GadElkarim JJ, Altshuler L, Moody T, Kumar A, Singh V, and Leow AD
- Subjects
- Adult, Bipolar Disorder diagnosis, Female, Humans, Image Enhancement methods, Male, Reproducibility of Results, Sensitivity and Specificity, Algorithms, Bipolar Disorder physiopathology, Brain physiopathology, Image Interpretation, Computer-Assisted methods, Magnetic Resonance Imaging methods, Nerve Net physiopathology, Wavelet Analysis
- Abstract
Advances in resting state fMRI and diffusion weighted imaging (DWI) have led to much interest in studies that evaluate hypotheses focused on how brain connectivity networks show variations across clinically disparate groups. However, various sources of error (e.g., tractography errors, magnetic field distortion, and motion artifacts) leak into the data, and make downstream statistical analysis problematic. In small sample size studies, such noise have an unfortunate effect that the differential signal may not be identifiable and so the null hypothesis cannot be rejected. Traditionally, smoothing is often used to filter out noise. But the construction of convolving with a Gaussian kernel is not well understood on arbitrarily connected graphs. Furthermore, there are no direct analogues of scale-space theory for graphs--ones which allow to view the signal at multiple resolutions. We provide rigorous frameworks for performing 'multi-resolutional' analysis on brain connectivity graphs. These are based on the recent theory of non-Euclidean wavelets. We provide strong evidence, on brain connectivity data from a network analysis study (structural connectivity differences in adult euthymic bipolar subjects), that the proposed algorithm allows identifying statistically significant network variations, which are clinically meaningful, where classical statistical tests, if applied directly, fail.
- Published
- 2013
- Full Text
- View/download PDF
37. Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions.
- Author
-
Lee GJ, Lu PH, Hua X, Lee S, Wu S, Nguyen K, Teng E, Leow AD, Jack CR Jr, Toga AW, Weiner MW, Bartzokis G, and Thompson PM
- Subjects
- Aged, Aged, 80 and over, Alzheimer Disease complications, Atrophy pathology, Cognitive Dysfunction complications, Depression complications, Disease Progression, Early Diagnosis, Female, Follow-Up Studies, Humans, Magnetic Resonance Imaging methods, Magnetic Resonance Imaging psychology, Male, Middle Aged, Nerve Fibers, Unmyelinated pathology, Neuroimaging methods, Neuropsychological Tests, Predictive Value of Tests, Psychiatric Status Rating Scales statistics & numerical data, Psychomotor Performance, Alzheimer Disease pathology, Alzheimer Disease psychology, Cognitive Dysfunction psychology, Depression psychology, Neuroimaging psychology
- Abstract
Background: Depression has been associated with higher conversion rates from mild cognitive impairment (MCI) to Alzheimer's disease (AD) and may be a marker of prodromal AD that can be used to identify individuals with MCI who are most likely to progress to AD. Thus, we examined the neuroanatomical changes associated with depressive symptoms in MCI., Methods: Two-hundred forty-three MCI subjects from the Alzheimer's Disease Neuroimaging Initiative who had brain magnetic resonance imaging scans at baseline and 2-year follow-up were classified into depressed (n = 44), nondepressed with other neuropsychiatric symptoms (n = 93), and no-symptom (NOSYMP; n = 106) groups based on the Neuropsychiatric Inventory Questionnaire. Tensor-based morphometry was used to create individual three-dimensional maps of 2-year brain changes that were compared between groups., Results: Depressed subjects had more frontal (p = .024), parietal (p = .030), and temporal (p = .038) white matter atrophy than NOSYMP subjects. Those whose depressive symptoms persisted over 2 years also had higher conversion to AD and more decline on measures of global cognition, language, and executive functioning compared with stable NOSYMP subjects. Nondepressed with other neuropsychiatric symptoms and NOSYMP groups exhibited no differences in rates of atrophy., Conclusions: Depressive symptoms were associated with greater atrophy in AD-affected regions, increased cognitive decline, and higher rates of conversion to AD. Depression in individuals with MCI may be associated with underlying neuropathological changes, including prodromal AD, and may be a potentially useful clinical marker in identifying MCI patients who are most likely to progress to AD., (Copyright © 2012 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
38. Hierarchical structural mapping for globally optimized estimation of functional networks.
- Author
-
Leow AD, Zhan L, Arienzo D, GadElkarim JJ, Zhang AF, Ajilore O, Kumar A, Thompson PM, and Feusner JD
- Subjects
- Adult, Female, Humans, Image Enhancement methods, Male, Middle Aged, Reproducibility of Results, Sensitivity and Specificity, Young Adult, Body Dysmorphic Disorders physiopathology, Connectome methods, Diffusion Tensor Imaging methods, Evoked Potentials, Visual, Nerve Net physiopathology, Visual Cortex physiopathology, Visual Perception
- Abstract
In this study, we propose a framework to map functional MRI (fMRI) activation signals using DTI-tractography. This framework, which we term functional by structural hierarchical (FSH) mapping, models the regional origin of fMRI brain activation to construct "N-step reachable structural maps". Linear combinations of these N-step reachable maps are then used to predict the observed fMRI signals. Additionally, we constructed a utilization matrix, which numerically estimates whether the inclusion of a specific structural connection better predicts fMRI, using simulated annealing. We applied this framework to a visual fMRI task in a sample of body dysmorphic disorder (BDD) subjects and comparable healthy controls. Group differences were inferred by comparing the observed utilization differences against 10,000 permutations under the null hypothesis. Results revealed that BDD subjects under-utilized several key local connections in the visual system, which may help explain previously reported fMRI findings and further elucidate the underlying pathophysiology of BDD.
- Published
- 2012
- Full Text
- View/download PDF
39. A framework for quantifying node-level community structure group differences in brain connectivity networks.
- Author
-
GadElkarim JJ, Schonfeld D, Ajilore O, Zhan L, Zhang AF, Feusner JD, Thompson PM, Simon TJ, Kumar A, and Leow AD
- Subjects
- Female, Humans, Image Enhancement methods, Male, Middle Aged, Reproducibility of Results, Sensitivity and Specificity, Algorithms, Brain anatomy & histology, Connectome methods, Diffusion Tensor Imaging methods, Image Interpretation, Computer-Assisted methods, Imaging, Three-Dimensional methods, Nerve Net anatomy & histology
- Abstract
We propose a framework for quantifying node-level community structures between groups using anatomical brain networks derived from DTI-tractography. To construct communities, we computed hierarchical binary trees by maximizing two metrics: the well-known modularity metric (Q), and a novel metric that measures the difference between inter-community and intra-community path lengths. Changes in community structures on the nodal level were assessed between generated trees and a statistical framework was developed to detect local differences between two groups of community structures. We applied this framework to a sample of 42 subjects with major depression and 47 healthy controls. Results showed that several nodes (including the bilateral precuneus, which have been linked to self-awareness) within the default mode network exhibited significant differences between groups. These findings are consistent with those reported in previous literature, suggesting a higher degree of ruminative self-reflections in depression.
- Published
- 2012
- Full Text
- View/download PDF
40. Accurate measurement of brain changes in longitudinal MRI scans using tensor-based morphometry.
- Author
-
Hua X, Gutman B, Boyle CP, Rajagopalan P, Leow AD, Yanovsky I, Kumar AR, Toga AW, Jack CR Jr, Schuff N, Alexander GE, Chen K, Reiman EM, Weiner MW, and Thompson PM
- Abstract
This paper responds to Thompson and Holland (2011), who challenged our tensor-based morphometry (TBM) method for estimating rates of brain changes in serial MRI from 431 subjects scanned every 6 months, for 2 years. Thompson and Holland noted an unexplained jump in our atrophy rate estimates: an offset between 0 and 6 months that may bias clinical trial power calculations. We identified why this jump occurs and propose a solution. By enforcing inverse-consistency in our TBM method, the offset dropped from 1.4% to 0.28%, giving plausible anatomical trajectories. Transitivity error accounted for the minimal remaining offset. Drug trial sample size estimates with the revised TBM-derived metrics are highly competitive with other methods, though higher than previously reported sample size estimates by a factor of 1.6 to 2.4. Importantly, estimates are far below those given in the critique. To demonstrate a 25% slowing of atrophic rates with 80% power, 62 AD and 129 MCI subjects would be required for a 2-year trial, and 91 AD and 192 MCI subjects for a 1-year trial., (Copyright © 2011 Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
41. Voxelwise genome-wide association study (vGWAS).
- Author
-
Stein JL, Hua X, Lee S, Ho AJ, Leow AD, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Dechairo BM, Potkin SG, Weiner MW, and Thompson P
- Subjects
- Aged, Alzheimer Disease genetics, Cognition Disorders genetics, Female, Genotype, Humans, Image Interpretation, Computer-Assisted, Magnetic Resonance Imaging, Male, Brain, Genome-Wide Association Study methods, Polymorphism, Single Nucleotide, Quantitative Trait, Heritable
- Abstract
The structure of the human brain is highly heritable, and is thought to be influenced by many common genetic variants, many of which are currently unknown. Recent advances in neuroimaging and genetics have allowed collection of both highly detailed structural brain scans and genome-wide genotype information. This wealth of information presents a new opportunity to find the genes influencing brain structure. Here we explore the relation between 448,293 single nucleotide polymorphisms in each of 31,622 voxels of the entire brain across 740 elderly subjects (mean age+/-s.d.: 75.52+/-6.82 years; 438 male) including subjects with Alzheimer's disease, Mild Cognitive Impairment, and healthy elderly controls from the Alzheimer's Disease Neuroimaging Initiative (ADNI). We used tensor-based morphometry to measure individual differences in brain structure at the voxel level relative to a study-specific template based on healthy elderly subjects. We then conducted a genome-wide association at each voxel to identify genetic variants of interest. By studying only the most associated variant at each voxel, we developed a novel method to address the multiple comparisons problem and computational burden associated with the unprecedented amount of data. No variant survived the strict significance criterion, but several genes worthy of further exploration were identified, including CSMD2 and CADPS2. These genes have high relevance to brain structure. This is the first voxelwise genome wide association study to our knowledge, and offers a novel method to discover genetic influences on brain structure., (Copyright 2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
42. Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease.
- Author
-
Stein JL, Hua X, Morra JH, Lee S, Hibar DP, Ho AJ, Leow AD, Toga AW, Sul JH, Kang HM, Eskin E, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Stephan DA, Webster J, DeChairo BM, Potkin SG, Jack CR Jr, Weiner MW, and Thompson PM
- Subjects
- Aged, Alzheimer Disease pathology, Genome-Wide Association Study, Genotype, Humans, Image Interpretation, Computer-Assisted, Magnetic Resonance Imaging, Nerve Degeneration pathology, Polymorphism, Single Nucleotide, Alzheimer Disease genetics, Nerve Degeneration genetics, Receptors, N-Methyl-D-Aspartate genetics, Temporal Lobe pathology
- Abstract
In a genome-wide association study of structural brain degeneration, we mapped the 3D profile of temporal lobe volume differences in 742 brain MRI scans of Alzheimer's disease patients, mildly impaired, and healthy elderly subjects. After searching 546,314 genomic markers, 2 single nucleotide polymorphisms (SNPs) were associated with bilateral temporal lobe volume (P<5 x 10(-7)). One SNP, rs10845840, is located in the GRIN2B gene which encodes the N-methyl-d-aspartate (NMDA) glutamate receptor NR2B subunit. This protein - involved in learning and memory, and excitotoxic cell death - has age-dependent prevalence in the synapse and is already a therapeutic target in Alzheimer's disease. Risk alleles for lower temporal lobe volume at this SNP were significantly over-represented in AD and MCI subjects vs. controls (odds ratio=1.273; P=0.039) and were associated with mini-mental state exam scores (MMSE; t=-2.114; P=0.035) demonstrating a negative effect on global cognitive function. Voxelwise maps of genetic association of this SNP with regional brain volumes, revealed intense temporal lobe effects (FDR correction at q=0.05; critical P=0.0257). This study uses large-scale brain mapping for gene discovery with implications for Alzheimer's disease., (Copyright 2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
43. Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals.
- Author
-
Hua X, Lee S, Hibar DP, Yanovsky I, Leow AD, Toga AW, Jack CR Jr, Bernstein MA, Reiman EM, Harvey DJ, Kornak J, Schuff N, Alexander GE, Weiner MW, and Thompson PM
- Subjects
- Aged, Cognition Disorders pathology, Databases, Factual, Female, Humans, Imaging, Three-Dimensional methods, Longitudinal Studies, Male, Temporal Lobe pathology, Time Factors, Alzheimer Disease pathology, Brain pathology, Brain Mapping methods, Disease Progression, Magnetic Resonance Imaging methods
- Abstract
Neuroimaging centers and pharmaceutical companies are working together to evaluate treatments that might slow the progression of Alzheimer's disease (AD), a common but devastating late-life neuropathology. Recently, automated brain mapping methods, such as tensor-based morphometry (TBM) of structural MRI, have outperformed cognitive measures in their precision and power to track disease progression, greatly reducing sample size estimates for drug trials. In the largest TBM study to date, we studied how sample size estimates for tracking structural brain changes depend on the time interval between the scans (6-24 months). We analyzed 1309 brain scans from 91 probable AD patients (age at baseline: 75.4+/-7.5 years) and 189 individuals with mild cognitive impairment (MCI; 74.6+/-7.1 years), scanned at baseline, 6, 12, 18, and 24 months. Statistical maps revealed 3D patterns of brain atrophy at each follow-up scan relative to the baseline; numerical summaries were used to quantify temporal lobe atrophy within a statistically-defined region-of-interest. Power analyses revealed superior sample size estimates over traditional clinical measures. Only 80, 46, and 39 AD patients were required for a hypothetical clinical trial, at 6, 12, and 24 months respectively, to detect a 25% reduction in average change using a two-sided test (alpha=0.05, power=80%). Correspondingly, 106, 79, and 67 subjects were needed for an equivalent MCI trial aiming for earlier intervention. A 24-month trial provides most power, except when patient attrition exceeds 15-16%/year, in which case a 12-month trial is optimal. These statistics may facilitate clinical trial design using voxel-based brain mapping methods such as TBM., (Copyright (c) 2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
44. A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly.
- Author
-
Ho AJ, Stein JL, Hua X, Lee S, Hibar DP, Leow AD, Dinov ID, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Stephan DA, DeCarli CS, DeChairo BM, Potkin SG, Jack CR Jr, Weiner MW, Raji CA, Lopez OL, Becker JT, Carmichael OT, and Thompson PM
- Subjects
- Aged, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Brain metabolism, Genetic Predisposition to Disease, Humans, Imaging, Three-Dimensional, Magnetic Resonance Imaging, Organ Size, Risk Factors, Alleles, Brain anatomy & histology, Obesity genetics, Proteins genetics
- Abstract
A recently identified variant within the fat mass and obesity-associated (FTO) gene is carried by 46% of Western Europeans and is associated with an approximately 1.2 kg higher weight, on average, in adults and an approximately 1 cm greater waist circumference. With >1 billion overweight and 300 million obese persons worldwide, it is crucial to understand the implications of carrying this very common allele for the health of our aging population. FTO is highly expressed in the brain and elevated body mass index (BMI) is associated with brain atrophy, but it is unknown how the obesity-associated risk allele affects human brain structure. We therefore generated 3D maps of regional brain volume differences in 206 healthy elderly subjects scanned with MRI and genotyped as part of the Alzheimer's Disease Neuroimaging Initiative. We found a pattern of systematic brain volume deficits in carriers of the obesity-associated risk allele versus noncarriers. Relative to structure volumes in the mean template, FTO risk allele carriers versus noncarriers had an average brain volume difference of approximately 8% in the frontal lobes and 12% in the occipital lobes-these regions also showed significant volume deficits in subjects with higher BMI. These brain differences were not attributable to differences in cholesterol levels, hypertension, or the volume of white matter hyperintensities; which were not detectably higher in FTO risk allele carriers versus noncarriers. These brain maps reveal that a commonly carried susceptibility allele for obesity is associated with structural brain atrophy, with implications for the health of the elderly.
- Published
- 2010
- Full Text
- View/download PDF
45. Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor-based morphometry.
- Author
-
Ho AJ, Hua X, Lee S, Leow AD, Yanovsky I, Gutman B, Dinov ID, Leporé N, Stein JL, Toga AW, Jack CR Jr, Bernstein MA, Reiman EM, Harvey DJ, Kornak J, Schuff N, Alexander GE, Weiner MW, and Thompson PM
- Subjects
- Aged, Disease Progression, False Positive Reactions, Female, Humans, Image Processing, Computer-Assisted, Longitudinal Studies, Male, Severity of Illness Index, Temporal Lobe pathology, Time Factors, Alzheimer Disease pathology, Brain pathology, Cognition Disorders pathology, Diffusion Tensor Imaging instrumentation, Diffusion Tensor Imaging methods
- Abstract
A key question in designing MRI-based clinical trials is how the main magnetic field strength of the scanner affects the power to detect disease effects. In 110 subjects scanned longitudinally at both 3.0 and 1.5 T, including 24 patients with Alzheimer's Disease (AD) [74.8 +/- 9.2 years, MMSE: 22.6 +/- 2.0 at baseline], 51 individuals with mild cognitive impairment (MCI) [74.1 +/- 8.0 years, MMSE: 26.6 +/- 2.0], and 35 controls [75.9 +/- 4.6 years, MMSE: 29.3 +/- 0.8], we assessed whether higher-field MR imaging offers higher or lower power to detect longitudinal changes in the brain, using tensor-based morphometry (TBM) to reveal the location of progressive atrophy. As expected, at both field strengths, progressive atrophy was widespread in AD and more spatially restricted in MCI. Power analysis revealed that, to detect a 25% slowing of atrophy (with 80% power), 37 AD and 108 MCI subjects would be needed at 1.5 T versus 49 AD and 166 MCI subjects at 3 T; however, the increased power at 1.5 T was not statistically significant (alpha = 0.05) either for TBM, or for SIENA, a related method for computing volume loss rates. Analysis of cumulative distribution functions and false discovery rates showed that, at both field strengths, temporal lobe atrophy rates were correlated with interval decline in Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog), mini-mental status exam (MMSE), and Clinical Dementia Rating sum-of-boxes (CDR-SB) scores. Overall, 1.5 and 3 T scans did not significantly differ in their power to detect neurodegenerative changes over a year. Hum Brain Mapp, 2010. (c) 2009 Wiley-Liss, Inc.
- Published
- 2010
- Full Text
- View/download PDF
46. Differentiating prenatal exposure to methamphetamine and alcohol versus alcohol and not methamphetamine using tensor-based brain morphometry and discriminant analysis.
- Author
-
Sowell ER, Leow AD, Bookheimer SY, Smith LM, O'Connor MJ, Kan E, Rosso C, Houston S, Dinov ID, and Thompson PM
- Subjects
- Adolescent, Brain Mapping methods, Child, Child, Preschool, Discriminant Analysis, Female, Follow-Up Studies, Humans, Male, Pregnancy, Prenatal Exposure Delayed Effects chemically induced, Retrospective Studies, Alcohol Drinking adverse effects, Alcohol Drinking pathology, Brain pathology, Diffusion Tensor Imaging methods, Ethanol adverse effects, Methamphetamine adverse effects, Prenatal Exposure Delayed Effects diagnosis
- Abstract
Here we investigate the effects of prenatal exposure to methamphetamine (MA) on local brain volume using magnetic resonance imaging. Because many who use MA during pregnancy also use alcohol, a known teratogen, we examined whether local brain volumes differed among 61 children (ages 5-15 years), 21 with prenatal MA exposure, 18 with concomitant prenatal alcohol exposure (the MAA group), 13 with heavy prenatal alcohol but not MA exposure (ALC group), and 27 unexposed controls. Volume reductions were observed in both exposure groups relative to controls in striatal and thalamic regions bilaterally and in right prefrontal and left occipitoparietal cortices. Striatal volume reductions were more severe in the MAA group than in the ALC group, and, within the MAA group, a negative correlation between full-scale intelligence quotient (FSIQ) scores and caudate volume was observed. Limbic structures, including the anterior and posterior cingulate, the inferior frontal gyrus (IFG), and ventral and lateral temporal lobes bilaterally, were increased in volume in both exposure groups. Furthermore, cingulate and right IFG volume increases were more pronounced in the MAA than ALC group. Discriminant function analyses using local volume measurements and FSIQ were used to predict group membership, yielding factor scores that correctly classified 72% of participants in jackknife analyses. These findings suggest that striatal and limbic structures, known to be sites of neurotoxicity in adult MA abusers, may be more vulnerable to prenatal MA exposure than alcohol exposure and that more severe striatal damage is associated with more severe cognitive deficit.
- Published
- 2010
- Full Text
- View/download PDF
47. Brain structure and obesity.
- Author
-
Raji CA, Ho AJ, Parikshak NN, Becker JT, Lopez OL, Kuller LH, Hua X, Leow AD, Toga AW, and Thompson PM
- Subjects
- Age Factors, Aged, Analysis of Variance, Body Mass Index, Diabetes Mellitus, Type 2 blood, Diabetes Mellitus, Type 2 pathology, Fasting blood, Female, Humans, Insulin blood, Magnetic Resonance Imaging, Male, Nerve Fibers, Myelinated pathology, Nerve Fibers, Unmyelinated pathology, Obesity blood, Organ Size, Racial Groups, Regression Analysis, Sex Factors, Brain pathology, Obesity pathology
- Abstract
Obesity is associated with increased risk for cardiovascular health problems including diabetes, hypertension, and stroke. These cardiovascular afflictions increase risk for cognitive decline and dementia, but it is unknown whether these factors, specifically obesity and Type II diabetes, are associated with specific patterns of brain atrophy. We used tensor-based morphometry (TBM) to examine gray matter (GM) and white matter (WM) volume differences in 94 elderly subjects who remained cognitively normal for at least 5 years after their scan. Bivariate analyses with corrections for multiple comparisons strongly linked body mass index (BMI), fasting plasma insulin (FPI) levels, and Type II Diabetes Mellitus (DM2) with atrophy in frontal, temporal, and subcortical brain regions. A multiple regression model, also correcting for multiple comparisons, revealed that BMI was still negatively correlated with brain atrophy (FDR <5%), while DM2 and FPI were no longer associated with any volume differences. In an Analysis of Covariance (ANCOVA) model controlling for age, gender, and race, obese subjects with a high BMI (BMI > 30) showed atrophy in the frontal lobes, anterior cingulate gyrus, hippocampus, and thalamus compared with individuals with a normal BMI (18.5-25). Overweight subjects (BMI: 25-30) had atrophy in the basal ganglia and corona radiata of the WM. Overall brain volume did not differ between overweight and obese persons. Higher BMI was associated with lower brain volumes in overweight and obese elderly subjects. Obesity is therefore associated with detectable brain volume deficits in cognitively normal elderly subjects., (2009 Wiley-Liss, Inc.)
- Published
- 2010
- Full Text
- View/download PDF
48. How does angular resolution affect diffusion imaging measures?
- Author
-
Zhan L, Leow AD, Jahanshad N, Chiang MC, Barysheva M, Lee AD, Toga AW, McMahon KL, de Zubicaray GI, Wright MJ, and Thompson PM
- Subjects
- Algorithms, Anisotropy, Computer Simulation, Diffusion, Female, Humans, Imaging, Three-Dimensional methods, Male, Models, Neurological, Young Adult, Corpus Callosum physiology, Diffusion Magnetic Resonance Imaging methods
- Abstract
A key question in diffusion imaging is how many diffusion-weighted images suffice to provide adequate signal-to-noise ratio (SNR) for studies of fiber integrity. Motion, physiological effects, and scan duration all affect the achievable SNR in real brain images, making theoretical studies and simulations only partially useful. We therefore scanned 50 healthy adults with 105-gradient high-angular resolution diffusion imaging (HARDI) at 4T. From gradient image subsets of varying size (6
- Published
- 2010
- Full Text
- View/download PDF
49. Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects.
- Author
-
Hua X, Lee S, Yanovsky I, Leow AD, Chou YY, Ho AJ, Gutman B, Toga AW, Jack CR Jr, Bernstein MA, Reiman EM, Harvey DJ, Kornak J, Schuff N, Alexander GE, Weiner MW, and Thompson PM
- Subjects
- Aged, Atrophy, Databases, Factual, Disease Progression, Follow-Up Studies, Humans, Imaging, Three-Dimensional methods, Linear Models, Neurodegenerative Diseases pathology, Neuropsychological Tests, Nonlinear Dynamics, Time Factors, Alzheimer Disease pathology, Brain pathology, Cognition Disorders pathology, Image Processing, Computer-Assisted methods, Magnetic Resonance Imaging
- Abstract
Tensor-based morphometry (TBM) is a powerful method to map the 3D profile of brain degeneration in Alzheimer's disease (AD) and mild cognitive impairment (MCI). We optimized a TBM-based image analysis method to determine what methodological factors, and which image-derived measures, maximize statistical power to track brain change. 3D maps, tracking rates of structural atrophy over time, were created from 1030 longitudinal brain MRI scans (1-year follow-up) of 104 AD patients (age: 75.7+/-7.2 years; MMSE: 23.3+/-1.8, at baseline), 254 amnestic MCI subjects (75.0+/-7.2 years; 27.0+/-1.8), and 157 healthy elderly subjects (75.9+/-5.1 years; 29.1+/-1.0), as part of the Alzheimer's Disease Neuroimaging Initiative (ADNI). To determine which TBM designs gave greatest statistical power, we compared different linear and nonlinear registration parameters (including different regularization functions), and different numerical summary measures derived from the maps. Detection power was greatly enhanced by summarizing changes in a statistically-defined region-of-interest (ROI) derived from an independent training sample of 22 AD patients. Effect sizes were compared using cumulative distribution function (CDF) plots and false discovery rate methods. In power analyses, the best method required only 48 AD and 88 MCI subjects to give 80% power to detect a 25% reduction in the mean annual change using a two-sided test (at alpha=0.05). This is a drastic sample size reduction relative to using clinical scores as outcome measures (619 AD/6797 MCI for the ADAS-Cog, and 408 AD/796 MCI for the Clinical Dementia Rating sum-of-boxes scores). TBM offers high statistical power to track brain changes in large, multi-site neuroimaging studies and clinical trials of AD.
- Published
- 2009
- Full Text
- View/download PDF
50. Comparing registration methods for mapping brain change using tensor-based morphometry.
- Author
-
Yanovsky I, Leow AD, Lee S, Osher SJ, and Thompson PM
- Subjects
- Aged, Aged, 80 and over, Algorithms, Female, Humans, Image Enhancement methods, Male, Middle Aged, Reproducibility of Results, Sensitivity and Specificity, Alzheimer Disease pathology, Brain pathology, Diffusion Magnetic Resonance Imaging methods, Image Interpretation, Computer-Assisted methods, Imaging, Three-Dimensional methods, Pattern Recognition, Automated methods, Subtraction Technique
- Abstract
Measures of brain changes can be computed from sequential MRI scans, providing valuable information on disease progression for neuroscientific studies and clinical trials. Tensor-based morphometry (TBM) creates maps of these brain changes, visualizing the 3D profile and rates of tissue growth or atrophy. In this paper, we examine the power of different nonrigid registration models to detect changes in TBM, and their stability when no real changes are present. Specifically, we investigate an asymmetric version of a recently proposed Unbiased registration method, using mutual information as the matching criterion. We compare matching functionals (sum of squared differences and mutual information), as well as large-deformation registration schemes (viscous fluid and inverse-consistent linear elastic registration methods versus Symmetric and Asymmetric Unbiased registration) for detecting changes in serial MRI scans of 10 elderly normal subjects and 10 patients with Alzheimer's Disease scanned at 2-week and 1-year intervals. We also analyzed registration results when matching images corrupted with artificial noise. We demonstrated that the unbiased methods, both symmetric and asymmetric, have higher reproducibility. The unbiased methods were also less likely to detect changes in the absence of any real physiological change. Moreover, they measured biological deformations more accurately by penalizing bias in the corresponding statistical maps.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.